-
EDITORIAL
Enhancing your organization’s expertise in quality and supply chain security
J. Fries
-
NEWS
-
FLOW CHEMISTRY
Benefits of adopting continuous flow synthesis
J. Knight, S. Conway
-
COMPANY PROFILE
SK pharmateco – a Force to be reckoned with
-
CONTINUOUS BIOPROCESSING
Continuous bioprocessing: When will we see commercial scale operations?
R. A. Rader
-
PAT
PAT leads the way in the adoption of continuous manufacturing processes – What are the benefits of PAT and the aspects to consider when deploying it?
M. Gadsby, F. Belvedere
-
PRODUCT FOCUS
IBSA innovative solutions for the nutraceutical market
-
CATALYSIS
Technical advances towards the industrial application of transaminases for the synthesis of chiral amines
A. Lako, R. Mendoca
-
CATALYSIS
Palladium catalysed cyclizations for N-Heterocycle synthesis: Recent developments
A. Moutayakine, A. J. Burke
-
CATALYSIS
3D printed catalytically active devices in organic synthesis
S. Rossi, A. Puglisi, L. Raimondi, M. Benaglia
-
DIGITALIZATION
The future of formulation stability testing – Doing more with less to drive innovation
C. Kelly
-
COMPANY PROFILE
ANGELINI PHARMA BROADENS ITS HPAPI CDMO CAPABILITIES
-
OLIGONUCLEOTIDES & PEPTIDES
Analytical methodologies to assure successful peptide synthesis when utilizing polystyrene/DVB resins
O. Al Musaimi, B. D. Summers, M. Alhassan, B. G. De La Torre, F. Albericio, S. Serban, A. Basso
-
OLIGONUCLEOTIDES & PEPTIDES
Peptide chemistry: in-silico development tools for an efficient process design
O. Ludemann-Hombourger, N. Petitjean
-
CLINICAL DEVELOPMENT
Non-clinical safety evaluation of vaccine: Strategic considerations to accelerate clinical development
S. Joseph
-
Column: REGULATION
Impurities in drugs: a toxicological approach is needed
A. Conto
-
EXCIPIENTS
Pharmaceutical excipients for solid oral dosage forms with specific functionalities for effective drug delivery
M. Fouché, J. Steenekamp, H. Hamman, J. S. Hamman
-
PANEL DISCUSSION
Panel Discussion – Italian Pharma Outlook
